Continuous Renal Replacement Therapy (CRRT) Market - Global Market Share, Trends, Analysis and Forecasts, 2023 - 2032

Continuous Renal Replacement Therapy (CRRT) plays a crucial role during the intensive care of patient with acute kidney disorders. Increasing number of patients suffering from chronic kidney diseases, prevalence of diabetes and high blood pressure due to sedentary lifestyle, increasing investment in product innovation, and intense competition in the market are the major factors driving the growth of continuous renal replacement therapy (CRRT) market globally.

The manufacturers of CRRT systems are continuously engaged in product innovation to develop advanced products at affordable prices to gain a competitive edge in the market. This has intensified the competition in the global continuous renal replacement therapy market.

Additionally, the number of patients suffering from chronic kidney disease is increasing across the globe due to prevalence of lifestyle disorders and is projected to increase in coming years. Consequently, the demand for continuous renal replacement therapy (CRRT) devices is anticipated to propel during the forecast period. The global continuous renal replacement therapy (CRRT) market is expected to grow significantly in coming years.

Asia Pacific contributed a prominent share to the global market in 2019 and is expected to be the fastest growing geography during the forecast period owing to increasing adoption of advanced modalities and increasing healthcare expenditure. Expanding population, and government initiatives towards strengthening the healthcare infrastructure & medical equipment manufacturing industry are anticipated to drive the growth of the continuous renal replacement therapy market during the forecast period.

North America contributed the largest share to the global continuous renal replacement therapy (CRRT) market in 2019 and is expected to witness prominent growth during the forecast period. Increasing incidences do chronic kidney diseases & rising requirement for dialysis equipment, presence of leading manufacturers of continuous renal replacement therapy modalities & consumables, and research and development focused on product innovation are the key factors driving the North America continuous renal replacement therapy market.

The report titled “Continuous Renal Replacement Therapy (CRRT) Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is the historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global continuous renal replacement therapy (CRRT) market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

For instance, Asahi Kasei Corporation reported revenues of USD 20.14 billion in 2018 and the product segment analysis of the company indicates that Material business segment of the company dominated revenue in 2018.

The global continuous renal replacement therapy (CRRT) market is segmented based on product type, type of modality, type of therapy, end user, and geography. Based on product type, the global continuous renal replacement therapy (CRRT) market is segmented into dialysates & replacement fluids, systems, and disposables. The disposables are sub-segmented into hemo-filters, blood sets (tubing sets), and others. Based on type of modality, the global continuous renal replacement therapy (CRRT) market is segmented into continuous veno-venous hemofiltration (CVVH), continuous veno-venous hemodiafiltration (CVVHDF), continuous veno-venous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). Based on type of therapy, the global continuous renal replacement therapy (CRRT) market is segmented into renal care, and non-renal care. Based on end user, the global continuous renal replacement therapy (CRRT) market is segmented into hospitals, dialysis centers, and others. Based on geography, the global continuous renal replacement therapy (CRRT) market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on continuous renal replacement therapy (CRRT).

Further, market share of prominent companies in the global continuous renal replacement therapy (CRRT) market would also be estimated. For instance, Asahi Kasei Corporation operates through three business segments namely Materials, Homes, and Health Care. The continuous renal replacement therapy (CRRT) products are delivered under Health Care business segment of the company with revenue contribution of US$ 2.96 billion in 2018.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the continuous renal replacement therapy (CRRT) disposable, fluids, and modality manufacturers. The global continuous renal replacement therapy (CRRT) market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.

Product portfolio would focus on all the products under the continuous renal replacement therapy (CRRT) business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global continuous renal replacement therapy (CRRT) market.

Major players active in the global continuous renal replacement therapy (CRRT) market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, NIPRO Corporation, NxStage Medical, Inc., and Toray Medical Co., Ltd.

Market Segmentation

Based on product type

• dialysates & replacement fluids
• systems
• disposables.

Based on type of modality

• continuous veno-venous hemofiltration (CVVH) 
• continuous veno-venous hemodiafiltration (CVVHDF)
• continuous veno-venous hemodialysis (CVVHD)
• slow continuous ultrafiltration (SCUF)

Based on type of therapy 

• renal care
• non-renal care

Based on end user

• hospitals
• dialysis centers
• others

By Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America